TENT5A and androgen insensitivity syndrome: As the susceptibility gene of AIS, Tent5a may be involved in the pathogenesis of AIS by regulating the formation of muscle fiber type I. These findings provide new therapeutic opportunities to correct muscle asymmetry for AIS with nonoperative management.